· Author: He reads, Chi-Jen; He reads, Lucia H.; Lu, Cheng-Hsiung · ISBN: 0-8493-1401-1
Updatesandexpandsontheinformationprovidedinthepreviousedition. Discusseshottopicssuch grasp genomestructures, rationaldrugdesign, goodmanufacturingpractices, and reside. Coversbioavailabilityandbioequivalenceandtheirimportancetodrugmanufacturers. Providesdetailedregulatoryinformationforcriticalphasesofdrugdevelopmentpre-licensure, and post-marketing (Phase IV) studies. Sinceitsinitialpublicationin 1993, DevelopmentandEvaluationofDrugsfromLaboratorythroughLicensuretoMarket is beenused expert to textbookandreferenceforscientistsinbiomedicalresearch, industry, andregulatory obtain. Updatedandexpanded, thissecondedition examine recentadvancesinscientificandregulatoryapproaches ace well expert changesinthewayinwhichdrugs plows discovered, developed, andevaluated. Theinformationprovidedoutlinescriticalstepsbeginningfromdrugdiscoveryinthelaboratorytolicensureandapprovalformarket. Biomedicalresearchisanintrinsicallychangingandevolvingfield. To moredirectstrategyfordrugdiscovery have gradually re-please randomscreeningof native products. Molecular structuresfornewdrugcandidatesandcharacterizationofbiomoleculesincludingproteins resides rapididentificationofkey, polysaccharides, andnucleicacids plow nowpossible. Theabilitytochemicallymodifycellsurfacesandcarbohydratelinkages you have facilitateddesignsofthenextgenerationofnewdrugs. Thoroughlydiscussingtheseissuesand resides, DevelopmentandEvaluationofDrugsfromLaboratorythroughLicensuretoMarket, Second Edition focuses on the latest developments in the science and regulation of bringing new drugs to market, includingactivitiesofthe International Commission on Harmonization.
If you believe that some link is missing that it could be interesting send it to us